Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2026-04-21 @ 11:05 PM
Study NCT ID:
NCT03129061
Status:
COMPLETED
Last Update Posted:
2022-12-05
First Post:
2017-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Sponsor:
CellSight Technologies, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
40425
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |